Key facts
- Notable investors include Assertive Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Medilabo RFP
- ·The full record, as it builds
Funding rounds
No funding rounds for Medilabo RFP are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medilabo RFP
Developer of healthcare products intended to serve people living with neurodegenerative disorders to maintain and improve their QOL through the development of innovative medicine. The company offers intranasal anti-dementia drugs for Alzheimer's disease prevention, thereby helping the patients for healthy aging, inhibit oligomers and dementia prevention.
- Sector
- Healthcare
- HQ
- Kyoto, Japan
- Founded
- 2018
- Website
- medilaborfp.com/
- Ownership
- Privately Held (backing)
Medilabo RFP doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medilabo RFP shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medilabo RFP in its N-PORT filings yet. We sweep new filings monthly.